.png){kind=icon}
返回
COVID-19: Complement, Coagulation, and Collateral Damage
.png){kind=icon}
OA
AI
DOI：10.4049/jimmunol.2000644.png)
.png){kind=icon}
.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Coronavirus disease of 2019 (COVID-19) is a highly contagious respiratory infection that is caused by the severe acute respiratory syndrome coronavirus 2. Although most people are immunocompetent to the virus, a small group fail to mount an effective antiviral response and develop chronic infections that trigger hyperinflammation. This results in major complications, including acute respiratory distress syndrome, disseminated intravascular coagulation, and multiorgan failure, which all carry poor prognoses. Emerging evidence suggests that the complement system plays a key role in this inflammatory reaction. Indeed, patients with severe COVID-19 show prominent complement activation in their lung, skin, and sera, and those individuals who were treated with complement inhibitors all recovered with no adverse reactions. These and other studies hint at complement's therapeutic potential in these sequalae, and thus, to support drug development, in this review, we provide a summary of COVID-19 and review complement's role in COVID-19 acute respiratory distress syndrome and coagulopathy.
Keyword:
RESPIRATORY SYNDROME CORONAVIRUS
FUNCTIONAL RECEPTOR
CLASSICAL PATHWAY
SARS-CORONAVIRUS
ACTIVATION
C5A
DISEASE
NEUTROPHILS
INHIBITION
PROTEIN
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
3.4
论文数:
3.7W
被引数:
9.9W
机构
引用论文
Role of RadA and DNA Polymerases in Recombination-Associated DNA Synthesis in Hyperthermophilic Archaea.png)
BiomoleculesOAAI
BiomoleculesIF0
OAAI分享收藏Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China武汉地区2019例新型冠状病毒感染患者临床特征分析LANCETOAAI
LANCETIF88.5
OAAI分享收藏
Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells注射未成熟树突状细胞后，人类效应T细胞功能的抗原特异性抑制OAAI
OAAI分享收藏Middle East Respiratory Syndrome Coronavirus Accessory Protein 4a Is a Type I Interferon AntagonistJOURNAL OF VIROLOGYOAAI
JOURNAL OF VIROLOGYIF3.8
OAAI分享收藏
查看更多内容